Christopher B. Primiano

2015

In 2015, Christopher B. Primiano earned a total compensation of $4.2M as Senior Vice President, Corporate Development, General Counsel and Secretary at Karyopharm Therapeutics, a 95% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$100,200
Option Awards$3,216,835
Salary$333,631
Stock Awards$537,300
Other$10,980
Total$4,198,946

Primiano received $3.2M in option awards, accounting for 77% of the total pay in 2015.

Primiano also received $100.2K in non-equity incentive plan, $333.6K in salary, $537.3K in stock awards and $11K in other compensation.

Rankings

In 2015, Christopher B. Primiano's compensation ranked 2,041st out of 13,638 executives tracked by ExecPay. In other words, Primiano earned more than 85.0% of executives.

ClassificationRankingPercentile
All
2,041
out of 13,638
85th
Division
Manufacturing
726
out of 5,190
86th
Major group
Chemicals And Allied Products
263
out of 1,854
86th
Industry group
Drugs
206
out of 1,528
87th
Industry
Pharmaceutical Preparations
164
out of 1,182
86th
Source: SEC filing on April 29, 2016.

Primiano's colleagues

We found three more compensation records of executives who worked with Christopher B. Primiano at Karyopharm Therapeutics in 2015.

2015

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2015

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2015

Justin Renz

Karyopharm Therapeutics

Chief Financial Officer

News

In-depth

You may also like